Cargando…
Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor
BACKGROUND: Fatigue is a common problem in immune-mediated inflammatory disease (IMID) patients, significantly impacting their quality of life. OBJECTIVES: In this study, we describe the pattern and characteristics of fatigue as a patient-reported adverse drug reaction (ADR) of biologics, and compar...
Autores principales: | van Lint, Jette A., Jessurun, Naomi T., Tas, Sander W., Vonkeman, Harald E., van Doorn, Martijn B. A., Hoentjen, Frank, Nurmohamed, Michael T., van Puijenbroek, Eugene P., van den Bemt, Bart J. F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10287789/ https://www.ncbi.nlm.nih.gov/pubmed/37010772 http://dx.doi.org/10.1007/s40259-023-00592-8 |
Ejemplares similares
-
Development of a Framework Structuring Themes in the Course of Adverse Drug Reactions from a Patient’s Perspective
por: van Lint, Jette A., et al.
Publicado: (2023) -
Discrepancy between patient‐ and healthcare provider‐reported adverse drug reactions in inflammatory bowel disease patients on biological therapy
por: Thomas, Pepijn W. A., et al.
Publicado: (2021) -
Adverse Drug Reactions from Real-World Data in Inflammatory Bowel Disease Patients in the IBDREAM Registry
por: Giraud, Eline L., et al.
Publicado: (2021) -
Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry”
por: van Vollenhoven, Ronald F, et al.
Publicado: (2023) -
Effectiveness of electronic drug monitoring feedback to increase adherence in patients with RA initiating a biological DMARD: a randomised clinical trial
por: Hebing, Renske CF, et al.
Publicado: (2022)